164 / 180
320
REFERENCIAS BIBLIOGRÁFICAS
1. Kumar A, Pati NT, Sarin SK. Use of stem cells for liver diseases-
current scenario. J Clin Exp Hepatol 2011; 1:17-26.
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838–
51.
3. Tsolaki E, Yannaki E. Stem cell-based regenerative opportunities
for the liver: State of the art and beyond. World J Gastroenterol.
2015; 21:12334-50.
4. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores
GJ, Dickson ER. Deaths on the liver transplant waiting list: an
analysis of competing risks. Hepatology 2006; 43:345-351.
5. Zarrinpar A, Busuttil RW. Liver transplantation: past, present
and future. Nat Rev Gastroenterol Hepatol 2013; 10:434-440.
6. Prósper F, Gavira JJ, Herreros J, Rábago G, Luquin R, Moreno J, et
al. Trasplante celular y terapia regenerativa con células madre.
An Sist Sanit Navar 2006; 29: 219-34.
7. Zern MA. Cell Transplantation to Replace Whole Liver
Transplantation. Gastroenterology 2009; 136:767-9
8. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells.
Lancet 2005; 366:592–602.
9. Lavon N, Benvenisty N. Study of Hepatocyte Differentiation
Using Embryonic Stem Cells, J Cell Biochem 2005; 96:1193-
202.
10. Moore KL, Persaud TVN, Torchia MG. The developing human:
Clinically orientated embriology. 9th edition. Philadelphia.
Elsevier/Saunders: 2013. Chapter 11, 213-244.
11. Sadri AR, Jeschke MG, Amini-Nik S. Advances in Liver
Regeneration: Revisiting Hepatic Stem/Progenitor Cells and
Their Origin. Stem Cells Int 2016; 2016:7920897
12. Ando H. Embryology of the biliary tract. Dig Surg 2010;
27:87-9.
13. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver
Organogenesis Promoted by Endothelial Cells Prior to Vascular
Function, Science 2001; 294:559-63.
14. Jung J, Zheng M, Goldfarb M, Zaret KS. Initiation of Mammalian
Liver Development From Endoderm by Fibroblast Growth
Factors, Science. 1999; 284:1998-2003.
15. Ochoa A.B, Juárez C.I, Rosales M.A, Barros P. La vía de
señalización Wnt-
ß
-catenina y su relación con cáncer. Cir Cir
2012; 80:389-398.
16. Sancho-Bru P. Posibilidades terapéuticas de las células madre
en el tratamiento de las enfermedades hepáticas. Gastroenterol
Hepatol 2011; 34:701-10.
17. Irfan A, Ahmed I. Could Stem Cell Therapy be the Cure in Liver
Cirrhosis? J Clin Exp Hepatol. 2015; 5:142-6.
18. Huebert RC, Rakela J. Cellular therapy for liver disease. Mayo
Clin Proc 2014; 89:414-24.
19. Hu C, Li L. In Vitro and in Vivo Hepatic Differentiation of Adult
Somatic Stem Cells and Extraembryonic Stem Cells for Treating
Los autores declaran no tener conflictos de interés, en relación a este artículo.
End Stage Liver Diseases. Stem Cells Int 2015; 2015:871972
20. Fellous TG, Islam S, Tadrous PJ, Elia G, Kocher HM, Bhattacharya
S, et al. Locating the Stem Cell niche and Tracing Hepatocyte
Lineages in Human Liver. Hepatology 2009; 49:1655-63.
21. Dorrell C, Erker L, Lanxon-Cookson KM, Abraham SL, Victoroff T,
Ro S, et al. Surface Markers for the Murine Oval Cell Response.
Hepatology 2008; 48:1282-91.
22. Boulter L, Lu WY, Forbes SJ. Differentiation of progenitors in the
liver: a matter of local choice. J Clin Invest 2013; 123:1867-73.
23. Hu M, Li S, Menon S, Liu B, Hu MS, Longaker MT, Lorenz HP.
Expansion and Hepatic Differentiation of Adult Blood-Derived
CD34+ Progenitor Cells and Promotion of Liver Regeneration
After Acute Injury. Stem Cells Transl Med 2016; 5:723-32.
24. Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for
liver fibrosis. Korean J Intern Med 2015; 30:580-9.
25. Yang D, Wang ZQ, Deng JQ, Liao JY, Wang X, Xie J, et al. Adipose-
derived stem cells: A candidate for liver regeneration. J Dig Dis
2015; 16:489-98.
26. Ishikawa T, Banas A, Hagiwara K, Iwaguro H, Ochiya T. Stem
Cells for Hepatic Regeneration: the Role of Adipose Tissue
Derived Mesenchymal Stem Cells, Curr Stem Cell Res Ther 2010;
5:182-9.
27. Chen G, Jin Y, Shi X, Qiu Y, Zhang Y, Cheng M, et al. Adipose-
derived stem cell-based treatment for acute liver failure. Stem
Cell Res Ther 2015; 6:40.
28. Zekri AR, Salama H, Medhat E, Musa S, Abdel-Haleem H,
Ahmed OS, et al. The impact of repeated autologous infusion of
haematopoietic stem cells in patients with liver insufficiency.
Stem Cell Res Ther. 2015; 6: 118.
29. Meier RP, Müller YD, Morel P, Gonelle-Gispert C, Bühler LH.
Transplantation of Mesenchymal Stem Cells for the Treatment
of Liver Diseases, is There Enough Evidence? Stem Cell Res 2013;
11:1348-64.
30. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM,
Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict
survival in patients with end-stage liver disease. Hepatology
2001; 33:464-70.
31. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R.
Transection of the oesophagus for bleeding oesophageal varices.
Br J Surg 1973; 60:646–649.
32. Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Humanmesenchymal
stem cell transfusion is safe and improves liver function in
acute-on-chronic liver failure patients. Stem Cells Transl Med
2012; 1:725-31.
33. Duan XZ, Liu FF, Tong JJ, Yang HZ, Chen J, Liu XY, Mao YL, Xin SJ,
Hu JH. Granulocyte-colony stimulating factor therapy improves
survival in patients with hepatitis B virus-associated acute-on-
chronic liver failure. World J Gastroenterol 2013; 19:1104-10.
[REV. MED. CLIN. CONDES - 2017; 28(2) 314-321]